Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis

Published:2021-05 Issue: Volume:Volume 15 Page:1945-1953
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Lin Li,Wang Weiming,Wu YiFan,Xie JingYuan,Li Xiao,Pan XiaoXia,Zhang Wen,Xu Jing,Cai YiKai,Ren Hong,Chen Nan

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference34 articles.

1. Advanced therapeutics in focal and segmental glomerulosclerosis

2. Rituximab therapy in nephrotic syndrome: implications for patients' management

3. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

4. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

5. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in risk of serious infections between patients with secondary versus primary nephropathy following rituximab treatment: a retrospective cohort study;Frontiers in Immunology;2024-06-11

2. The efficacy and safety of rituximab with or without glucocorticoid in inducing remission of MCD with different clinical presentations in adults: a retrospective study;Clinical Kidney Journal;2024-05-03

3. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study;American Journal of Nephrology;2023-11-14

4. Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review;American Journal of Kidney Diseases;2023-02

5. B cell phenotype, activity, and function in idiopathic nephrotic syndrome;Pediatric Research;2022-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3